A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples